Elias S. Sotirchos

Elias S. Sotirchos

Neurology

Floor 5
Baltimore, MD 21287

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 131 publications

Effectiveness and Safety of Plasmapheresis in MOGAD Attacks: A Systematic Review and Meta-Analysis.

Effectiveness and Safety of Plasmapheresis in MOGAD Attacks: A Systematic Review and Meta-Analysis.

Journal: Neurology

Published: July 22, 2026

TRUE-MOGAD Score: A Novel Scoring System to Identify MOGAD Among Positive MOG-IgG Test Results.

TRUE-MOGAD Score: A Novel Scoring System to Identify MOGAD Among Positive MOG-IgG Test Results.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: July 13, 2026

Interleukin 6 Receptor Blockade for Relapse Prevention in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Interleukin 6 Receptor Blockade for Relapse Prevention in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Journal: JAMA neurology

Published: July 13, 2026

Association of epiretinal membranes with disability in people with multiple sclerosis.

Association of epiretinal membranes with disability in people with multiple sclerosis.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: July 06, 2026

Application of the 2024 McDonald Criteria in Individuals With Nonspecific Symptoms or Incidental Imaging Findings in a Multicenter Study.

Application of the 2024 McDonald Criteria in Individuals With Nonspecific Symptoms or Incidental Imaging Findings in a Multicenter Study.

Journal: Neurology

Published: June 12, 2026

Proteomic Age Acceleration in Multiple Sclerosis Precedes Symptom Onset and Associates with Severity.

Proteomic Age Acceleration in Multiple Sclerosis Precedes Symptom Onset and Associates with Severity.

Journal: medRxiv : the preprint server for health sciences

Published: May 04, 2026

Diagnostic performance of central vein sign and paramagnetic rim lesion integration for multiple sclerosis.

Diagnostic performance of central vein sign and paramagnetic rim lesion integration for multiple sclerosis.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: April 21, 2026

Comparative Effectiveness of Disease-Modifying Treatments in Double Seronegative Neuromyelitis Optica Spectrum Disorder.

Comparative Effectiveness of Disease-Modifying Treatments in Double Seronegative Neuromyelitis Optica Spectrum Disorder.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: April 16, 2026

Effect of ocrelizumab on rates of retinal atrophy in relapsing multiple sclerosis.

Effect of ocrelizumab on rates of retinal atrophy in relapsing multiple sclerosis.

Journal: Multiple sclerosis journal - experimental, translational and clinical

Published: April 07, 2026

TRUE-MOGAD Score: A Novel Scoring System to Identify MOGAD Among Positive MOG-IgG Test Results.

TRUE-MOGAD Score: A Novel Scoring System to Identify MOGAD Among Positive MOG-IgG Test Results.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: April 01, 2026

Influence of OSCAR-IB criteria on test-retest reliability of Spectralis SD-OCT retinal thickness measurements in people with Multiple Sclerosis.

Influence of OSCAR-IB criteria on test-retest reliability of Spectralis SD-OCT retinal thickness measurements in people with Multiple Sclerosis.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: March 30, 2026

Ganglion Cell Layer Compared With Inner Plexiform Layer Atrophy After Optic Neuritis Associated With NMOSD, MOGAD, and MS.

Ganglion Cell Layer Compared With Inner Plexiform Layer Atrophy After Optic Neuritis Associated With NMOSD, MOGAD, and MS.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: March 25, 2026

Showing 1-12 of 131

Last Updated: 09/26/2026